Taiwan FDA registration bd88f7993d0136d9d26ada21f26b5b54
Encore Early Pregnancy (urine) testing system
TW: 安可早孕(尿液)測試系統
Registration details
- Analysis ID
- bd88f7993d0136d9d26ada21f26b5b54
- Customs Code
- DHA04200033600
Company information
- Manufacturer
- ACON BIOTECH (HANGZHOU) CO., LTD.
- Manufacturer Country
- China
- Authorized Representative
- MIN JIER FIRM
Product details
- Intended Use
- Immunoassay was used to qualitatively analyze human chorionic gonadal hormone (hCG) in female urine in vitro. It can be detected when the concentration of hCG in the urine is as high as 25 mIU/mL.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Jan 17, 2007
- Expiry Date
- Jan 17, 2012
- Cancellation Date
- Apr 30, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Encore Early Pregnancy (urine) testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bd88f7993d0136d9d26ada21f26b5b54 and manufactured by ACON BIOTECH (HANGZHOU) CO., LTD.. The authorized representative in Taiwan is MIN JIER FIRM.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices